Tapentadol Production Cost Reports

The report provides a detailed analysis essential for establishing a tapentadol production plant. It encompasses all critical aspects necessary for tapentadol production, including the cost of tapentadol production, tapentadol plant cost, tapentadol production costs, and the overall tapentadol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a tapentadol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Tapentadol is a centrally acting synthetic opioid analgesic that provides relief for moderate to severe acute pain. It is used in post-surgical or injury-related discomfort and chronic pain, including musculoskeletal pain unresponsive to non-opioid therapies. Its dual mechanism involves mu-opioid receptor agonism to block pain signals and norepinephrine reuptake inhibition to improve descending inhibitory pain pathways.

It is effective for both nociceptive and neuropathic pain, like diabetic peripheral neuropathy. It has a lower risk of certain opioid side effects compared to traditional opioids. It is available as immediate or extended-release oral tablets and is utilised when alternative treatments fail.

The market for tapentadol is driven by rising cases of chronic pain (like musculoskeletal disorders and diabetic neuropathy). The rise in the ageing population and increasing demand for opioid alternatives with better tolerability profiles contribute to its market growth. The post-operative pain management needs and innovations in formulations like oral, injectable, and extended release boost their demand.

The regional healthcare expansions and simplifications in regulatory factors support generic options. The industrial tapentadol procurement is affected by rising API and import costs, regulatory compliance, and competitive pricing in branded and generics options. Other factors like cold-chain logistics, geopolitical risks, patent dynamics, and economic pressures influence its sourcing strategies.

Raw Material for Tapentadol Production

According to the tapentadol production plant project report, the key raw materials used in the production of tapentadol include 1-(3-methoxyphenyl)propan-1-one, dimethylamine hydrochloride, and paraformaldehyde.

Production Process of Tapentadol

The extensive tapentadol production cost report consists of the following major industrial production process:

1. From 1-(3-methoxyphenyl)propan-1-one: The production process of tapentadol involves several steps. First, a Mannich reaction of 1-(3-methoxyphenyl)propan-1-one with dimethylamine hydrochloride, paraformaldehyde, HCl, and L-proline in ethanol under reflux yields the aminoketone. After that, the Grignard addition takes place using 3-bromoanisole and magnesium in THF, which adds to this ketone, producing the tertiary alcohol. Then, reductive deoxygenation via sulfonate activation and Pd/C hydrogenation removes the hydroxyl group. After that, O-demethylation with HBr followed by basification gives tapentadol free base. Finally, salt formation with HCl in acetone leads to the formation of tapentadol hydrochloride.

Tapentadol is a synthetic opioid analgesic acting as a mu-opioid receptor agonist and norepinephrine reuptake inhibitor. It has a molecular formula C14H23NO with a molecular weight of 221.34 g/mol, and its HCl salt has the molecular formula of 257.80 g/mol. It has the (1R,2R) configuration that has a phenolic hydroxyl (pKa ~9.3–10) and a tertiary amine (pKa ~9.4–10) that enable zwitterionic forms at neutral pH. It appears as a white to off-white crystalline powder with logP ~2.87–3.08 and high permeability. Its hydrochloride salt has a melting point of 115 degree Celsius and is freely soluble in water.